Navigation Links
AbbVie to Present at Morgan Stanley Global Healthcare Conference
Date:8/27/2013

NORTH CHICAGO, Ill., Aug. 27, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 10, 2013. Richard A. Gonzalez, chairman and chief executive officer, and Scott Brun, M.D., vice president, pharmaceutical development, will take part in a question and answer session at 11:55 a.m. Central time.

A live audio webcast of the question and answer session will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com.  An archived edition of the session will be available later that day.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.


'/>"/>
SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational Students with Cystic Fibrosis Pursuing their Goals of Higher Education
2. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
3. StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie
4. AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference
5. AbbVie Declares Dividend and Announces Share Repurchase Program
6. Cambridge Semantics to Present on Smart Data and Competitive Intelligence Informatics at 2013 Pharma CI Conference & Exposition
7. iLab Solutions to Present SRA International Webinar for Research Administrators
8. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE MIDWEST IDEAS INVESTOR CONFERENCE
9. Bayer CropScience Presents on Bee Health and Stewardship at International Pollinator Conference
10. GW Pharmaceuticals to Present at the 33rd Annual Canaccord Genuity Growth Conference
11. Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... /CNW/ - Resverlogix Corp. (TSX:RVX) (the "Company") today ... research program with Emerald Logic, a leader ... Technology (FACET), Emerald Logic analyzed Resverlogix,s complete ... each of 798 patients who participated in ... SUSTAIN and ASSURE. The objective of this ...
(Date:3/4/2015)... Irvine, CA (PRWEB) March 04, 2015 ... research leader in Personalized Medicine, is excited to ... “Incorporating Genetic Testing to Optimize the Management of ... be available at Medscape.com for the next year. ... medical professionals how to recognize inadequate pain treatments, ...
(Date:3/4/2015)... , March 4, 2015  BioClinica®, ... and technology provider, today announced that clinical ... countries convened at its annual European User ... to discuss the use of its ... BioClinica,s eClinical technologies include: the Microsoft Office-Smart ...
(Date:3/4/2015)... March 04, 2015 Follow us ... one of the fastest growing technologies in the life ... subcellular visualization is driving growth in nucleic acid detection ... understanding of gene expressions will continue to benefit the ... in fields ranging from pharma, biotech, food & beverage ...
Breaking Biology Technology:Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
... and Harvard Deploys Isilon Clustered Storage to ... Growth, SEATTLE, Sept. 15 Isilon(R) Systems ... that the Broad,Institute of MIT and Harvard, one ... has deployed Isilon IQ clustered storage to,streamline mission-critical ...
... Inc.,(NYSE: BMR ) today announced that its board of ... share of common stock. The,dividend is equivalent to an annualized ... that its board of directors has declared a,dividend of $0.46094 ... Stock for the period from July 16, 2008 through,October 15, ...
... Sept. 12 Fougera, a division of Nycomed,US ... Clotrimazole Cream USP,1%. The generic formulation compares to ... three sizes: 15g tubes (NDC # 0168-0133-15), 30g ... 0168-0133-46)., "The approval of Clotrimazole Cream is ...
Cached Biology Technology:Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing 2Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing 3BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends 2
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... corporate website ( http://www.nxt-id.com/ ) as part of its ... wallet. The Company launched its new consumer website for ... Pereira , CEO of NXT-ID said, "Our new corporate ...
(Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... some other type of transcendent entity answer prayer? , ... study published in the March journal Research on Social ... of social work in the College of Human Services ... 17 major studies on the effects of intercessory prayer ...
... Worldwide, billions of people lack access to a reliable ... To address the problem, the United Nations established the ... of people without sustainable access to safe drinking water ... launched in 2000 as part of the U.N. Millennium ...
... When a virus infects a person, it triggers a series ... life or death consequences. , Usually, the result is ... virus and the infected person’s recovery. But in the case ... Marburg and Lassa fever viruses, as well as the influenza ...
Cached Biology News:Does God answer prayer? ASU research says 'yes' 2Failure to meet United Nations sanitation target could affect millions of the world's poorest 2Failure to meet United Nations sanitation target could affect millions of the world's poorest 3New study may show how to forestall a fatal, virus-caused immune-system meltdown 2New study may show how to forestall a fatal, virus-caused immune-system meltdown 3
...
Newborn Calf Serum US Origin...
SPDP-Trinitrophenol (TNP) Bovine Serum Albumin...
Acrylamide, 500 g. Assay: > 99.9%, acrylic acid: < 0.001%. Conductivity (35%): < 2 umhos/cm.Risks: 45, 46, 48, 23, 24, 25 ; Safety Precautions: 53, 44. Category: Nucleotides & Enzymes & Biochemicals...
Biology Products: